Phoenixville, PA, United States of America

Joseph Weinstock

This inventor holds 65 USPTO granted patents, plus 1 CIPO patent, primarily in Cancer Treatment (CPC class 5483). Top assignees: Smithkline Beecham Corporation, Smithkline Corporation, Smithkline Beckman Corporation. Active years: 1976-2022.

USPTO Granted Patents = 65

% Patents Active = 92.3

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.0

ph-index = 12

Forward Citations = 450(Granted Patents)

Forward Citations (Not Self Cited) = 420(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Philadelphia, PA (US) (1993)
US (1994)
Phoenixville, PA (US) (1976 - 2003)
Wayne, PA (US) (2001 - 2019)
Sarasota, FL (US) (2022)

Company Filing History:

23 out of 2,198

Smithkline Beecham Corporation

patents

21 out of 344

Smithkline Corporation

patents

14 out of 207

Smithkline Beckman Corporation

The Children's Hospital of Philadelphia

patents

6. 3 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1976-2022

Loading Chart...

Areas of Expertise:

USP7 Inhibitors

Cancer Agents

Angiotensin II Antagonists

Fatty Acid Synthase Inhibitors

Macrophage Scavenger Receptors

IL-8 Receptor Antagonists

Neoplastic Compounds

Age-Related Macular Degeneration

Combinatorial Libraries

Benzimidazoles

Imidazolyl Compounds

Antihypertensive Agents

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11273154 - Azole compounds as ubiquitin-specific protease USP7 inhibitors (2022-03-15),

2. 10292973 - Covalent irreversible inhibitors of USP7 as anti-cancer agents (2019-05-21),

3. 9717717 - Methods of treating cancer through the inhibition of USP7 and immune system modulation (2017-08-01),

4. 9072749 - Treatment of age-related macular degeneration (2015-07-07),

5. 8680139 - Anti-neoplastic compounds, compositions and methods (2014-03-25),

6. 6653347 - IL-8 receptor antagonists (2003-11-25),

7. 6620826 - Endothelin receptor antagonists (2003-09-16),

8. 6559179 - Fatty acid synthase inhibitors (2003-05-06),

9. 6498187 - Fatty acid synthase inhibitors (2002-12-24),

10. 6458845 - Macrophage scavenger receptor antagonists (2002-10-01),

11. 6255298 - Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases (2001-07-03),

12. 6210900 - Method of encoding a series of combinatorial libraries and developing structure activity relationships (2001-04-03),

13. 5929249 - Substituted imidazolyl-alkyethio-aldanoic acids (1999-07-27),

14. 5773512 - Compounds and methods (1998-06-30),

15. 5728842 - Substituted imidazolyl-alkylthio-alkanoic acids (1998-03-17),

Title: The Innovative Journey of Joseph Weinstock

Introduction: Joseph Weinstock, a talented inventor based in Phoenixville, PA, has made significant contributions to the field of technology with his creative solutions and groundbreaking ideas.

Latest Patents: Joseph Weinstock holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing new solutions to complex problems.

Career Highlights: Throughout his career, Joseph Weinstock has demonstrated a keen ability to identify gaps in the market and develop innovative products that meet the needs of consumers. His dedication to pushing the boundaries of technology has led to the successful commercialization of several of his inventions.

Collaborations: Joseph Weinstock has collaborated with leading tech companies and research institutions to further develop his inventions and bring them to the market. His collaborative spirit and passion for innovation have earned him recognition among his peers in the industry.

Conclusion: Joseph Weinstock's relentless pursuit of innovation and his commitment to creating impactful solutions have solidified his reputation as a respected inventor in the technology sector. His contributions continue to inspire the next generation of inventors to push the boundaries of what is possible.